Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $271

Benzinga · 3d ago
Barclays analyst Andrew Mok maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $240 to $271.